Efalizumab, CAS 214745-43-4

Product Description: Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Leonardi CL. Efalizumab: an overview. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S98-104. /[2]Berger JR, et al. Monoclonal antibodies and progressive multifocal leukoencephalopathy. MAbs. 2009 Nov-Dec;1(6):583-9. /[3]Koszik F, et al. Efalizumab modulates T cell function both in vivo and in vitro. J Dermatol Sci. 2010 Dec;60(3):159-66.

CAS Number: 214745-43-4

Molecular Weight: N/A

Compound Purity: 98.77

Research Area: Others

Solubility: H2O

Target: Integrin

• Artikelnummer: MEXHY-P9947-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9947-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated